Stocktoria
Kalaris Therapeutics, Inc. KLRS
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-07-30
Kalaris Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 176,863 | $511,134 | 0.77% |
| CITADEL ADVISORS LLC | 95,772 | $389,792 | 0.42% |
| TWO SIGMA INVESTMENTS, LP | 23,847 | $97,057 | 0.1% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.